Trial · NCT02520011
Results by group32
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 32
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stage 2 CM Relapsed/Refractory | Complete Remission (CR) | 6 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stage 2 ACM Relapsed/Refractory | Complete Remission (CR) | 2 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stage 1 ACM Relapsed/Refractory | Complete Remission (CR) | 8 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stages 1 and 2 ACM Relapsed/Refractory | Complete Remission (CR) | 21 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stage 1 Newly Diagnosed ACM | Complete Remission (CR) | 6 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | All Stages and Cohorts (Including Randomized Stage): ACM Total | Complete Remission (CR) | 27 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stage 2 CM Relapsed/Refractory | CR with Incomplete Neutrophil Recovery (Cri) | 0 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stage 2 ACM Relapsed/Refractory | CR with Incomplete Neutrophil Recovery (Cri) | 3 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stage 1 ACM Relapsed/Refractory | CR with Incomplete Neutrophil Recovery (Cri) | 5 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stages 1 and 2 ACM Relapsed/Refractory | CR with Incomplete Neutrophil Recovery (Cri) | 15 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stage 1 Newly Diagnosed ACM | CR with Incomplete Neutrophil Recovery (Cri) | 2 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | All Stages and Cohorts (Including Randomized Stage): ACM Total | CR with Incomplete Neutrophil Recovery (Cri) | 17 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stage 2 CM Relapsed/Refractory | Partial Remission (PR) | 0 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stage 2 ACM Relapsed/Refractory | Partial Remission (PR) | 0 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stage 1 ACM Relapsed/Refractory | Partial Remission (PR) | 1 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stages 1 and 2 ACM Relapsed/Refractory | Partial Remission (PR) | 1 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stage 1 Newly Diagnosed ACM | Partial Remission (PR) | 1 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | All Stages and Cohorts (Including Randomized Stage): ACM Total | Partial Remission (PR) | 2 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stage 2 CM Relapsed/Refractory | Resistant/Relapsed Disease | 5 | participants | |
| Complete Response (CR) Rate in Patients With Relapsed or Refractory AML | Stage 2 ACM Relapsed/Refractory | Resistant/Relapsed Disease | 5 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02520011/results